ArticleCase reports in oncology

Entrectinib Response to ROS1-Fusion-Positive Non-Small-Cell Lung Cancer That Progressed on Crizotinib with Leptomeningeal Metastasis: A Case Report.

Hiromune Sawada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.